Propanc publishes recombinant proenzyme study in peer-reviewed journal
Go back to Propanc publishes recombinant proenzyme study in peer-reviewed journal| (NASDAQ: PPCB) | Delayed: 0.64 +0.01 (1.59%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.63 | 52 Week High | $ | |||
| Open | $0.66 | 52 Week Low | $ | |||
| Day High | $0.67 | P/E | N/A | |||
| Day Low | $0.63 | EPS | $ | |||
| Volume | 47,762 | |||||

